Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,020.59 +11.21 (+1.11%)
Streaming Delayed Price Updated: 12:52 PM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly Unveils New Data Showing Longer Survival With Breast Cancer Drug In Late-Stage Study ↗
Via Stocktwits
News headline image
Eli Lilly Rises, Again, After EMA Recommends Mounjaro For Children As Young As 10 ↗
On Friday, Europe's drug regulator recommended extending the use of Eli Lilly's Mounjaro to children as young as 10. 
Via Investor's Business Daily
News headline image
The Best Turnaround Stock to Invest $1,000 in Right Now ↗
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term. 
Via The Motley Fool
News headline image
Dow Jones, Russell 2000 Hit Highs, Buoyed By Fed; Oracle, Broadcom Weigh On Techs: Weekly Review ↗
GE Vernova was a big winner. Eli Lilly and two biotechs released obesity drug data. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
News headline image
Dow Jones Industrial Average: An Intraday Record - What's Driving the Blue-Chip Surge?
The venerable Dow Jones Industrial Average (DJIA) has once again captured headlines, surging to unprecedented intraday record highs around December 2025. This remarkable ascent, which saw the blue-chip... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Eli Lilly’s New Obesity Treatment Shows Weight Loss Up To 71.2 Lbs, Reduces Pain In Trial ↗
Via Stocktwits
News headline image
FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch ↗
FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from May. 
Via Benzinga
News headline image
Think Eli Lilly Is Expensive? This Metric Says Otherwise. ↗
The pharmaceutical stock can still deliver. 
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Topped the Market on Thursday ↗
A proposed new federal law could provide some competitive guardrails for the company's most important product. 
Via The Motley Fool
News headline image
Market Soars to Unprecedented Heights: What Comes Next After Today's Record Run?
The financial markets roared to an emphatic close on December 11, 2025, with major indices shattering previous records in a session defined by widespread optimism and robust investor confidence. This... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Navigating Nuance: Tech Innovation, Healthcare Revival, and Energy's Evolving Landscape Shape Late 2025 Markets
As December 2025 unfolds, global financial markets are characterized by a delicate balance of cautious optimism and persistent uncertainty. A "Santa Claus rally" sentiment prevails, fueled by... 
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
News headline image
Value Stocks Stage a Comeback Bid Amidst Persistent Growth Dominance
The financial markets in late 2025 present a complex narrative, a tug-of-war between the long-reigning titans of growth and a resurgent, yet often overshadowed, cohort of value stocks. While the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Eli Lilly (LLY) Stock Is Up, What You Need To Know
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the morning session after the company announced highly positive Phase 3 trial results for its next-generation weight loss... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Small-Cap Surge Signals Major Market Rebalancing: Investors Pivot from Tech to Broader Economy
Small-capitalization stocks are currently experiencing an unprecedented surge, with the benchmark Russell 2000 index shattering all-time records in early December 2025. This remarkable rally, which saw... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Eli Lilly's Retatrutide Soars: Unprecedented Trial Results Propel Pharma Giant, Ignite Obesity Market
Eli Lilly and Company (NYSE: LLY) has once again sent ripples through the pharmaceutical world with the announcement of groundbreaking Phase 3 trial results for its investigational obesity drug,... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% ↗
The active ingredient retatrutide works on three gut hormones. 
Via Investor's Business Daily
News headline image
US Stock Market Rides High: Fed Rate Cut Fuels Optimism as Indices Eye Record Peaks
New York, NY – December 10, 2025 – The U.S. stock market is currently experiencing a robust rally, with major indices positioned tantalizingly close to their all-time highs. This bullish sentiment,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
Via MarketBeat
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Following a significant price increase due to the company's industry-leading weight loss drugs, investors must now consider what comes next. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The Top 3 Investment Themes That Will Dominate 2026 ↗
Via MarketBeat
News headline image
What&#39;s Happening With French Biotech Abivax Stock On Wednesday? ↗
Abivax shares rise on renewed takeover speculation tied to Eli Lilly following strong Phase 3 trial results. 
Via Benzinga
News headline image
3 Absurdly Cheap Stocks That Look Like Steals Right Now ↗
These stocks are down more than 20% this year, but they possess lots of upside potential over the long term. 
Via The Motley Fool
Topics Economy World Trade
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Investors are currently so focused on one type of drug that even good companies are being left on the sidelines. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly&#39;s $6 Billion Alabama Site To Make Next-Gen Weight Loss Pills ↗
Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create 450 jobs. 
Via Benzinga
News headline image
Manufacturing Renaissance Fuels Job Market Amidst Shifting Sands
The American labor market is experiencing a fascinating dichotomy as it navigates late 2024 and 2025. While overall job creation has shown signs of moderation and significant revisions to earlier... 
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
News headline image
Eli Lilly Stock Falls For 9 Straight Days Despite $6B Push To Build A US Plant For Its Oral GLP-1 Pill ↗
Eli Lilly is expanding its U.S. manufacturing footprint with a new Alabama facility that will add thousands of jobs. 
Via Stocktwits
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Silver Shines as Global Tariff Storm Gathers: A Safe-Haven and Strategic Imperative in 2025
As global trade tensions escalate dramatically throughout late 2024 and 2025, marked by a surge in protectionist policies and tit-for-tat tariffs, silver has emerged as a dual-threat asset: a critical... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Global Markets Brace for Fed Decision Amidst Divergent Policies and Geopolitical Crosscurrents
Global financial markets are treading a cautious path as December 9, 2025, unfolds, with investors keenly focused on the impending U.S. Federal Reserve's interest rate decision. The highly anticipated... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
JPMorgan's Cautious Outlook Rattles Dow Jones Amidst Strong Performance
JPMorgan Chase & Co. (NYSE: JPM), a titan of the financial industry and a significant component of the Dow Jones Industrial Average (DJIA), recently experienced a notable shift in market sentiment.... 
Via MarketMinute
Topics Artificial Intelligence Credit Cards Economy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.